A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

Government price negotiations under the Inflation Reduction Act may hinder biosimilar development, impacting drug costs and ...

Over the coming years, the Inflation Reduction Act aims to help those with Medicare save on their prescription drug costs. Learn more.

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

Adam Colborn, JD, associate vice president of congressional affairs at AMCP, shares insights on the impact of the Most ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

The Inflation Reduction Act (IRA) made changes to the way drugs are covered and reimbursed in Medicare. It has been ...

Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

Down here in Louisiana, we’ve got enough financial worries, especially after four years of Biden-induced inflation. Yet, ...

Adam Gray (D-CA), and Neal Dunn (R-FL) introduced the Protecting Patient Access to Cancer and Complex Therapies Act. This ...